After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.

Mar 6, 2024 · A once-weekly oral regimen can keep HIV suppressed as well as daily pills, according to study results presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).. In a phase II clinical trial, 94% of people who switched to weekly islatravir and lenacapavir pills maintained an undetectable viral load, matching the viral suppression rate of those who stayed on ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.

PEP is a method of preventing HIV infection. In the UK the recommended first-line PEP medications are generally well tolerated by most people. Nonetheless, some people do have short-term side-effects.

Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Emtricitabine 200mg capsule 1 Common: Nausea, diarrhoea, vomiting, indigestion, headache, dizziness, weakness, fatigue, raised liver enzyme, amylase or creatine kinase levels, raised blood sugar and triglyceride levels, rash, itching, skin darkening, insomnia, abnormal dreams

What is Biktarvy?. Biktarvy is a medication used to treat HIV. It is a combination of three separate antiretroviral drugs in one pill, taken once a day. It combines 50mg of bictegravir, 200mg of emtricitabine and 25mg of tenofovir alafenamide in a purplish-brown tablet with ‘GSI’ on one side and ‘9883’ on the other side of the tablet.. How does Biktarvy work?

Antiretroviral drug chart Generic name Trade name Formulation Standard adult dose Pills/ day Major side effects Food requirements Tenofovir disoproxil

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all the information being up to date as of July 2024.

Feb 23, 2024 · Monitoring of CD4/CD8 ratios should not be abandoned as HIV treatment programmes switch to streamlined monitoring, researchers from the University of Wisconsin argue in the journal AIDS.. Highlighting recently published research that shows the value of CD4/CD8 ratios for predicting who is at greater risk of cancer and weak vaccine responses, they say that the CD4/CD8 ratio remains an important ...

Acute HIV infection is the immediate period after HIV infection and refers to the first month after you have been infected, while the term primary HIV infection is the six-month period after infection. This early period represents an important time in terms of infectiousness and damage to the immune system. Seroconversion symptoms